Original Contribution

Am J Hypertens (2005) 18, 714–719; doi: 10.1016/j.amjhyper.2005.03.738

Caffeine Tolerance is Incomplete: Persistent Blood Pressure Responses in the Ambulatory Setting

Noha H. Farag MD1, Andrea S. Vincent PhD1,2, Bong Hee Sung PhD4, Thomas L. Whitsett MD3, Michael F. Wilson MD4 and William R. Lovallo PhD1,2

  1. 1Veterans Affairs Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
  2. 2Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
  3. 3Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
  4. 4Department of Medicine and Cardiology, State University of New York and Kaleida Health, Millard Fillmore Hospitals, Buffalo, New York, USA.

Correspondence: Dr. Noha H. Farag, VA Medical Center (151A), 921 NE 13th Street, Oklahoma City, OK 73104 E-mail: noha-farag@ouhsc.edu

Received 7 July 2004; Accepted 30 October 2004.

Top

Abstract

Background: Caffeine in dietary doses is a well-established pressor agent. Tolerance to this pressor effect occurs in only about half of regular consumers in acute laboratory tests. The clinical significance of this incomplete tolerance depends on whether the pressor effect is maintained throughout the day with repeated intake. Therefore, we examined the ability of a standard dose of caffeine (250 mg times 3) to maintain a blood pressure (BP) elevation during 18 hours of ambulatory BP monitoring (ABPM) after 5 days of regular daily intake of varying background doses.

Methods: Eighty-five men and women completed a four-week double blind, crossover trial. During each week, subjects consumed capsules totaling 0, 300, or 600 mg/day of caffeine in 3 divided doses. On day 6, they consumed capsules with either 0 or 250 mg at 9:00 am and 1:00 pm, in the laboratory, and again at 6:00 pm during ABPM. Tolerance was defined as a reduction in the diastolic BP response to two challenge doses given in the lab in response to increasing daily intake. Data were analyzed using multivariate repeated measures analysis of variance.

Results: BP responses to caffeine above those found on placebo-placebo (P-P) week were found for both tolerance groups when caffeine was consumed after a week of receiving a placebo. However, only the low tolerance group showed increases, above those found on P-P week, after 300 mg/day in systolic/diastolic BP during the waking hours (mean plusminus standard error of the mean = 2.8 plusminus 1.1, P = .01/2.2 plusminus 0.9, P = .02) and in systolic BP during sleep (2.3 plusminus 1, P = .03).

Conclusions: Persistent elevations in BP occurring on a daily basis in some habitual caffeine consumers may hold clinical significance.

Keywords:

caffeine, tolerance, blood pressure, ambulatory

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT